Wednesday, September 17, 2014

Three Colorado Bioscience Companies Present at the Inaugural White Hat Life Science Investor Conference in Phoenix

Colorado BioScience Association (CBSA) congratulates the three Colorado headquartered companies selected to present at the inaugural White Hat Life Science Investor Conference being held September 17 and 18 at the Grand Hyatt in Phoenix, AZ. The announcement is made by April Giles, CBSA President and CEO, who says, “We’re excited to be a partner in the 2014 White Hat Life Science Investor Conference and to help showcase three of Colorado’s promising bioscience companies during the event.” The participating Colorado companies include EndoShape, Fluonic and ViroCyt.

The conference, spearheaded by the Arizona BioIndustry Association (AZBio), is presented by the National Venture Capital Association and leading life science associations of the Rocky Mountain Southwest Region, including the CBSA. This conference is showcasing 34 of the region’s top life science companies to interested investors including business development professionals from large pharmaceutical, biotechnology, medical device and diagnostic companies.

“The Rocky Mountain and Southwest Regions have become increasingly recognized for their growth in the bioscience and heath care innovations. The White Hat Life Science Investor Conference will act as another opportunity to highlight the work being done in Colorado and the surrounding region while at the same time bringing new potential partners and investors into our community,” Giles said.

Colorado bioscience companies selected to present in the 2014 White Hat Investor Conference:

* EndoShape, Inc., Boulder – EndoShape’s mission is to commercialize novel medical devices based on its proprietary polymer technology. EndoShape is focused on the coil embolization and occlusion market. EndoShape is currently commercializing the Medusa™ Vascular Plug which is FDA 510(k) cleared for sale in the United States. Visit,

* Fluonic, Inc., Boulder - Fluonic is a privately held medical device company dedicated to making infusion drug delivery safer for patients through the development of a new generation of infusion devices and information systems, driven by a breakthrough MEMS flow sensor technology. Fluonic infusion products improve patients’ safety and compliance while improving medical staff productivity and reducing costs, which will set a new standard of care for the industry. Visit,

* ViroCyt, LLC, Boulder - ViroCyt, LLC was created in late 2012 to focus on the commercialization of novel technologies that enable rapid quantification of viruses, such as the Virus Counter® 3100. The Company’s mission is to provide the tools that deliver meaningful improvements to critical biotechnology processes such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role. Visit,

For more information and a complete listing of presenting companies, visit the conference website at

Link to the related PitchEngine Social Media Release

Tuesday, September 16, 2014

Video Highlights: BioWest 2014, Marriott City Center, Denver

BioWest 2014 Video Highlights

Founders Breakfast Health and Wellness Panel: Introductions By Steve VanNurden -

Health/Wellness Panel: Jandel Allen-Davis on the Kaiser Model -

Health/Wellness Panel: James Hill on Extreme Weight Loss TV -

Health/Wellness Panel: Len Tacconi on What Works -

C-Level Unplugged: Larry Gold, Chairman of the Board, SomaLogic -
C-Level Unplugged: Shar Matin, COO, Spectranetics -
CEO Panel: Bill Aldrich, CEO, EndoShape -

CEO Panel: David Brunel, CEO, Biodesix -

CEO Panel: Byron Hewett, CEO, SomaLogic -

BioTalks Excerpt: Jonathan Norris – Investments, Exits -

BioTalks Excerpt: David Gary, Clinical Trials Ethics -

BioTalks Excerpt: Iya Khalil on Big Data Healthcare -

BioTalks Excerpt: Robert Atkinson, How Colorado Ranks -

BioTalks Excerpt: Rhea May, Superbugs -

BioTalks Excerpt: Larry Blankenship, Valley of Death -

BioTalks Excerpt: Mark Sirangelo, Innovation in Colorado -

BioTalks Excerpt: Lindsay Guerdrum, Beer Bioscience -

Russell Slifer – About the USPTO -

Russell Slifer – USPTO Rocky Mtn Regional Office -
Venture Showcase Sponsors and Judges

dBMEDx Winning Venture Showcase Presentation -

KromaTiD Venture Showcase Presentation -

Mighty Oak Medical Venture Showcase Presentation -

FDA Commissioner Hamburg Opening Remarks to Closing Keynote -

Link to the related InnovatioNews article

Link to the related Denver Post article

Link to the related Denver Business Journal article

Friday, September 12, 2014

Coverage Recap: dBMEDx Wins the Venture Showcase Competition at BioWest 2014

Link to Digital Journal

Link to CNBC

Link to Yahoo! Finance

Link to Metro Denver News

Link to BioSpace

DBJ: 'FDA could be source of innovation, Hamburg says'

Quoting from the September 11th posting by Greg Avery:

"Hamburg’s vision is for the FDA to use that position to help researchers and companies make more effective new treatments and prove new medical advances more quickly, she said.

'We have a lot more to offer than has historically been appreciated,' said Hamburg, U.S. Commissioner of Food and Drugs since 2009. 'The regulator has a very different role than the innovator or the academic researcher, but we can be a very effective partner for both.'

It’s a theme Hamburg is stressing as U.S. Rep. Dianna DeGette, a Democrat representing Denver, and U.S. Rep. Fred Upton, R- Michigan, spearhead a bipartisan '21st Century Cures' initiative in Congress aimed at creating legislation to spur innovation and efficiency in medicine and health care. That could involve changes to FDA rules and budget.

Hamburg gave the closing keynote speech Wednesday at the Colorado BioScience Association’s annual BioWest convention. She had testified before DeGette and Upton in Washington D.C. earlier that same day."

Link to the Denver Business Journal

DP Business: 'Colorado biotech firms trying to innovate efficiently'

Quoting the September 11th overview by Aldo Svaldi:

"Efficiency and cost savings were themes repeated often at the annual conference of the Colorado BioScience Association.

Once upon a time, it was enough for biotech firms to show how innovative their latest offerings were, even if they weren't fully proven and they cost more than whatever they were replacing.

After the passage of the Affordable Care Act, proof something works matters more than its whiz bang. And anything new needs to cut costs rather than inflate them.

'It needs to be a better and less-expensive solution,' said Bill Aldrich, CEO of EndoShape, a Boulder start-up that is developing polymer plugs and coils designed to replace more expensive platinum products now in use in blood vessels."

Link to the full article at

BioWest 2014: 'Biannual conference and expo highlights life science industry progress, challenges'

Quoting from the Sept 11 InnovatioNews:

"If the nation’s health care system can be shaken up and transformed into a more proactive force, it could help companies improve their bottom lines through healthier employees.

That was one of the messages Wednesday from a panel of health care experts kicking off BioWest 2014, the biannual conference and life science industry expo hosted by the Colorado BioScience Association...

...Lunch keynote speaker Russell Slifer, director of the newly-opened Rocky Mountain office of the U.S Patent and Trademark Office in Denver, said the office is hiring patent examiners and judges and expects to have more than 100 examiners and 20 judges in place within the year...

...Winner of the $7,500 Venture Showcase pitch competition was dBMedx, a Littleton company that makes non-invasive scanning technology...

...The BioWest conference also included a closing keynote by Margaret Hamburg, U.S. Food and Drug Administration commissioner."

Link to the full article

Link to InnovatioNews February profile of dBMEDx

Colorado Med Device Company dBMEDx Wins the Venture Showcase Competition at BioWest 2014

dBMEDx (Littleton) won the 2014 Venture Showcase competition at the BioWest Conference and Expo yesterday at the Marriott City Center Denver, receiving the $7,500 cash prize. The announcement is made by April Giles, Colorado BioScience Association (CBSA) President and CEO who says, “We are very proud to announce dBMEDx as the winner of the Venture Showcase. The check presentation was an exciting end to the BioWest Conference. The award not only includes the cash prize of $7,500 but also includes recognition and exposure for the company. ” This award is sponsored by Dorsey and Whitney LLP and The Metro Denver Economic Development Corporation. BioWest, the Rocky Mountain Region's premier medical device and biotechnology conference, is organized by the CBSA and held every other year.

dBMEDx is a Colorado-based medical device development company that is creating clinical decision and patient monitoring devices using its patented, non-invasive scanning technology. These devices combine the power and safety of ultrasound with sophisticated image processing electronics and software to provide simple, fully automated and completely noninvasive diagnostic measurements.  Fully automated means that very little training is required and the user does not need any experience with ultrasound to use our devices. To enable this level of automation, dBMEDx has successfully created and patented an extremely compact, wireless, 3D scan engine.

The scan engine, which can be held in the palm of the hand, includes a complete 3D ultrasound imaging machine and automated image processor within a small, sealed tube.  The system also includes an integrated Bluetooth radio and rechargeable battery, which is inductively charged. The company is in the process of commercializing the first application for this technology, the BBS Revolution™ device for automated bladder volume measurement, and has a range of pipeline of products for other clinical applications as well. Visit:

Video of winning Venture Showcase pitch by dBMEDx CEO David Shine:

The Venture Showcase format allowed each company’s lead executive to make a 15-minute presentation with an accompanying slide deck explaining their technology and business plan to a panel of judges in front of a live audience. This year's judging panel included the following:

• Michael Weiner, Partner, Dorsey
• Ned Scheetz, Managing Director, Aphelion Capital
• Steve VanNurden, President and CEO, Fitzsimons Redevelopment Authority

The three 2014 Venture Showcase finalists included:

dBMEDx – Littleton
KromaTiD, Inc. - Fort Collins
Mighty Oak Medical – Englewood

The BioWest Conference was attended by more than 300 industry leaders, government representatives, executives, researchers, investors and entrepreneurs. “We look forward to the continued growth of the bioscience industry and presenting the conference in again 2016,” Giles concludes.

Link to the related Business Wire

Link to the PitchEngine Social Media Release

Tuesday, September 09, 2014

InnovatioNews: 'CBSA BioWest conference to include BioTalks and C-Level Unplugged at 2014 event"

Quoting from the Sept 5th posting:

"Colorado BioScience Association is launching a new feature called “BioTalks” at the annual BioWest Conference and Expo set for Sept. 10.

BioTalks will include eight fast-paced presentations about 'the big and bold ideas in the bioscience industry,' according to CBSA.

The BioTalks are scheduled for 10:45 a.m. and 3 p.m.

...The 2014 CBSA BioWest Conference and Expo will be held at the Marriott City Center, 1701 California St., in downtown Denver."

Link to

Coverage Recap: 'Biowest Expo Showcases New Technologies, Products & Services For 300+ Attendees; Features FDA Commissioner Hamburg As Lead Keynote'

Link to

Link to Food and Drug Administration News Today

Link to Yahoo! Finance

Link to World News

Link to iStockAnalyst

Sunday, September 07, 2014

It's #MiceBucketChallenge for Cat Care Society on Facebook

It's #MiceBucketChallenge for Cat Care Society on Facebook.

Particulars: Load up a bucket with your soft mice toys, make a video of your cat taking the challenge by ever so gently dumping them on your cat (similar to the recent #IceBucketChallenge for ALS), challenge other kitties to do the same and, most important, make a donation to Cat Care Society in Lakewood, Colorado. We're suggesting a minimum $10 donation for each challenge. You can donate online at - here's the link: - or you can mail or drop a check by the shelter during business hours: 5787 W. 6th Ave., Lakewood, CO 80214. Remember to make sure you let us know your donation is for #MiceBucketChallenge. If you don't Facebook (or make videos), please still consider donating to help the shelter cats in Lakewood by participating in the Cat Care Society #MiceBucketChallenge. Thank you!

Sample videos:

Calico Rita

Munchkin Cat Corporal Reggie Waddle

Lynx Point Siamese Mix Bombay
 (He'd posted his #MiceBucketChallenge before Reggie did his. Corporal Reggie didn't know when he challenged his friend Bombay in his video.)

Friday, September 05, 2014

Artists Call for Entry: Tails of the Painted Cats 2015

Artists are now being recruited for 2015
Cat Care Society’s signature fundraiser, Tails of the Painted Cats, is now accepting applications and designs for its 5th annual event, celebrating the program's 100th painted cat.

Fast Facts for Artists...Important Dates:
  • Deadline for designs: November 1, 2014  
  • Jurist for the 2015 project is noted Colorado artist Cheryl St. John. Learn more about her at: 
  • Participating artists will be notified November 14 
  • Fiberglass cat forms will be distributed at the beginning of January 
  • Artists have three months to paint. Cats due back April 4, 2015 
  • A $50 stipend is provided to each artist to help with art supplies 
  • Artists receive a ticket to the Gala Dinner & Auction at Pinehurst Country Club, Saturday, October 10, 2015 
  • Painted Cats tour throughout the community for thee months during Summer 2015 
For an application, please contact TOPC Art Coordinator Jane McFadden Dorsey at or call 303.239.9680, ext. 16.

For more information about Tails of the Painted Cats: 

Facebook page:

View all the past Painted Cats on Flickr:

2014 Painted Cats Gallery

2013 Painted Cats Gallery

2012 Painted Cats Gallery

2011 Painted Cats Gallery

Thursday, September 04, 2014

CBSA Launches New “BioTalks” at BioWest 2014 in Denver; People Talking About Big, Bold Ideas

Colorado BioScience Association (CBSA) is launching new “BioTalks” at BioWest this year. These are eight fast-paced presentations about the big and bold ideas in the Bioscience Industry. The announcement is made by CBSA President and CEO April Giles, who says, “This year we’ve added energy and excitement to our lineup with the new BioTalk segments during regular programming and the new C-Level Unplugged interviews on center stage in the Expo Hall. Further, we’re very excited about the number of high caliber keynote speakers at BioWest 2014, including FDA Commissioner Dr. Margaret Hamburg, Russell Slifer the newly appointed Director of the Rocky Mountain Region’s Satellite U.S. Patent and Trade Mark Office, CEO presentations, and the wide variety of products and services on display in the Expo Hall.”

The 2014 BioWest Conference and Expo, is September 10, at the Marriott City Center, 1701 California Street, Denver.

BioTalks are scheduled at both 10:45 a.m. and 3:00 p.m.

Morning Session:

Trends in Healthcare: Investments & Exits Jonathan Norris, Managing Director, Silicon Valley Bank 

Ethics in Clinical Trials David Gary, RN, MS, Director, Human Research Protection Program, Catholic Health Initiatives/CHI Institute for Research & Innovation (CIRI)

Harnessing the Power of Real World Data to Identify What Works for Whom in Healthcare Iya Khalil, Ph.D., Executive Vice President and Co-Founder, GNS Healthcare

Afternoon Session:

Cultivating the Innovation Economy Robert Atkinson, President, Information Technology and Innovation Foundation

The Truth behind Superbugs Rhea May, Ph.D., Research Scientist, Sharklet Technologies

Leveraging Outsourcing to Bridge the Valley of Death: Advantages & Pitfalls Larry Blankenship, Executive Director, Evergreen Research

Industry Cross Collaboration Mark Sirangelo, Chief Innovation Officer, State of Colorado; Corporate VP of Space Systems, Sierra Nevada Corp 

Beer Fermentation Science: Yeast Strains & Sensory Perception Lindsay Guerdrum, Sensory Specialist, New Belgium Brewing

Also new this year: C-Level Unplugged 

In addition to BioTalk presentations, BioWest 2014 is also debuting two sessions of “C-Level Unplugged: Conversations with top level leadership.” The morning session, 9:20 – 9:35, will feature a fast-paced interview on the Exhibit Hall stage with Larry Gold, Chairman of the Board, SomaLogic. The afternoon session, 1:15 – 1:30 pm, features Shahriar (Shar) Matin, Chief Operating Officer of Spectranetics. Jim Wilson, partner, EY, will conduct the interview for both sessions during the conference.

About BioWest 2014 | September 10, 2014 | #BioWest2014 

The BioWest Conference is a one day event attended by more than 300 industry leaders, government representatives, executives, researchers, investors and entrepreneurs. The conference features speakers Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration (her ‘Update on the FDA’ keynote will occur at 4:45 pm) sponsored by Dohmen and keynote panelists; Jandel Allen-Davis, M.D., Vice President, Government and External Relations, Kaiser Permanente Colorado; James Hill, Ph.D. is Professor of Pediatrics and Medicine at the University of Colorado School of Medicine; Len Tacconi, President, HMR Weight Management Services Corp., a subsidiary of Merck & Co. Inc.; sponsored by the Fitzsimons Redevelopment Authority and Russell Slifer, Director, United States Patent and Trademark, Rocky Mountain Regional Office sponsored by Sheridan Ross PC. The full schedule of the day’s events is found at:

Registration is now open at Rates for members start at $325 and $375 for non-members and passes for the expo hall and reception only are $125 for members and $150 for non-members. Group rates are available for companies and organizations. BioWest 2014 also includes an Exhibit Hall with over 40 exhibitors showcase new technologies, products and services to attendees. Conference Sponsors include: AdvaMed, Amgen, BIO, BioFrontiers Institute, DePuy Synthes, DaVita Clinical Research, Dorsey & Whitney LLP, Dohmen Life Science Services, EY, Evergreen Research, Fitzsimons Redevelopment Authority, Fisher Scientific, Metro Denver EDC, The Mead Consulting Group, Quintiles, SomaLogic, Sheridan Ross PC, Square 1 Bank, Silicon Valley Bank and TerumoBCT.

Link to the PitchEngine social media release